AI assistant
BioAge Labs, Inc. — Director's Dealing 2024
Sep 27, 2024
33722_dirs_2024-09-27_ae1c20bd-0bc7-492e-a5c9-84ae7b39ee29.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAge Labs, Inc. (BIOA)
CIK: 0001709941
Period of Report: 2024-04-17
Reporting Person: Morgen Eric (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-25 | Stock Option (Right to Buy) | $18 | A | 4952 | Acquired | 2034-09-24 | Common Stock (4952) | Indirect |
| 2024-04-17 | Stock Option (Right to Buy) | $8.39 | A | 257973 | Acquired | 2034-04-16 | Common Stock (257973) | Direct |
| 2024-04-17 | Stock Option (Right to Buy) | $8.39 | A | 13598 | Acquired | 2034-04-16 | Common Stock (13598) | Indirect |
Footnotes
F1: The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 1, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2: Represents an employee stock option directly held by the reporting person's spouse.
F3: This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a).
F4: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F5: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.